Clinical Trials Update: Oct. 31, 2006
Irritable Bowel Syndrome (IBS) Psoriasis and Psoriatic Disorders Sexual Dysfunction
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Irritable Bowel Syndrome (IBS)
This study will evaluate the safety and effectiveness of an investigational drug in women to treat diarrhea-predominant irritable bowel syndrome. Women may be included who are at least 18 and who are willing to have an endoscopic and/or radiologic bowel evaluation, if they have not received one in the past five years. Participants may not have any serious medical or surgical condition, colon cancer, Crohn's disease or ulcerative colitis, or be pregnant or breast feeding.
The research site is in Laurel, Md.
Psoriasis and Psoriatic Disorders
This study will evaluate a twice-daily topical treatment for body psoriasis in adolescents. Eligible patients must have body psoriasis, such as on arms, legs, chest, or back. The study involves six office visits (some visits require blood draws) with a board-certified dermatologist, and includes free treatment for up to eight weeks, and compensation for time and travel.
The research site is in Shreveport, La.
This is a research study of an investigational drug for symptoms of decreased sexual desire. Volunteers at least 18 who are premenopausal and have a lack of desire to have sex may be included if these symptoms have persisted for six months or longer. Participants may be compensated for time and travel at $50.00 per visit up to a total of $350.00.
The research site is in Charlottesville, Va.
Copyright 2006 Thomson CenterWatch. All rights reserved.